Old Web
English
Sign In
Acemap
>
authorDetail
>
Takafumi Yanase
Takafumi Yanase
Lung cancer
Medicine
Ramucirumab
Docetaxel
Internal medicine
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Drug-Induced Kidney Injury Caused by Osimertinib: Report of a Rare Case.
2021
Nephron
Takayuki Niitsu
Terumasa Hayashi
Junji Uchida
Takafumi Yanase
Satoshi Tanaka
Munenori Kuroyama
Kiyonobu Ueno
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancer: A multicenter retrospective cohort study.
2021
Journal of Geriatric Oncology
Kinnosuke Matsumoto
Akihiro Tamiya
Yuji Inagaki
Yoshihiko Taniguchi
Yoshinobu Matsuda
Hayato Kawachi
Motohiro Tamiya
Satoshi Tanizaki
Junji Uchida
Kiyonobu Ueno
Takafumi Yanase
Hidekazu Suzuki
Shinji Atagi
Show All
Source
Cite
Save
Citations (0)
Impact of docetaxel plus ramucirumab on metastatic site in previously treated patients with non-small cell lung cancer: a multicenter retrospective study.
2021
Translational lung cancer research
Kinnosuke Matsumoto
Akihiro Tamiya
Yoshinobu Matsuda
Yoshihiko Taniguchi
Shinji Atagi
Hayato Kawachi
Motohiro Tamiya
Satoshi Tanizaki
Junji Uchida
Kiyonobu Ueno
Takafumi Yanase
Hidekazu Suzuki
Tomonori Hirashima
Show All
Source
Cite
Save
Citations (1)
1